Defining novel therapeutic strategies in MLL-rearranged leukemias

被引：0
|
作者：
Faber, J. [1 ,2 ]
Krivtsov, A. [2 ]
Stubbs, M. [2 ]
Armstrong, S. [2 ]
机构：
[1] Univ Kinderklin Mainz, Mainz, Germany
[2] Childrens Hosp Boston, Boston, MA USA
来源：
EUROPEAN JOURNAL OF PEDIATRICS | 2009年 / 168卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：381 / 382
页数：2
相关论文
共 50 条
  • [21] In focus: MLL-rearranged leukemia
    de Boer, J.
    Walf-Vorderwuelbecke, V.
    Williams, O.
    LEUKEMIA, 2013, 27 (06) : 1224 - 1228
  • [22] BET INHIBITOR AS A NOVEL THERAPEUTIC APPROACH FOR THE TREATMENT OF MLL-REARRANGED INFANT ACUTE LEUKEMIA
    Bardini, M.
    Trentin, L.
    Rizzo, F.
    Vieri, M.
    Savino, A. M.
    Castro, P. Garrido
    Fazio, G.
    Van Roon, E.
    Smithers, N.
    Prinjha, R.
    Stam, R.
    Pieters, R.
    te Kronnie, G.
    Basso, G.
    Biondi, A.
    Cazzaniga, G.
    HAEMATOLOGICA, 2016, 101 : 323 - 323
  • [23] AF4-AF9 interaction as a potential therapeutic target for MLL-rearranged mixed-lineage leukemias
    Chang, Ming-Jin
    Lin, Jeffrey J.
    Hemenway, Charles S.
    CANCER RESEARCH, 2011, 71
  • [24] Identifying Methylation Changes Driving Evolution of Relapse in MLL-Rearranged Acute Lymphoblastic Leukemias
    Kostadinov, Rumen
    Scharpf, Robert
    Sabunciyan, Sarven
    Magoon, Daniel
    Irizarry, Rafael
    Brown, Patrick
    BLOOD, 2014, 124 (21)
  • [25] Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
    Munoz-Lopez, Alvaro
    Romero-Moya, Damia
    Prieto, Cristina
    Ramos-Mejia, Veronica
    Agraz-Doblas, Antonio
    Varela, Ignacio
    Buschbeck, Marcus
    Palau, Anna
    Carvajal-Vergara, Xonia
    Giorgetti, Alessandra
    Ford, Anthony
    Lako, Majlinda
    Granada, Isabel
    Ruiz-Xiville, Neus
    Rodriguez-Perales, Sandra
    Torres-Ruiz, Raul
    Stam, Ronald W.
    Fuster, Jose Luis
    Fraga, Mario F.
    Nakanishi, Mahito
    Cazzaniga, Gianni
    Bardini, Michela
    Cobo, Isabel
    Bayon, Gustavo F.
    Fernandez, Agustin F.
    Bueno, Clara
    Menendez, Pablo
    STEM CELL REPORTS, 2016, 7 (04): : 602 - 618
  • [26] Bet Inhibition as a Novel Therapeutic Approach for the Treatment of MLL-Rearranged Acute Lymphoblastic Leukemia in Infants
    Bardini, M.
    Trentin, L.
    Rizzo, F.
    Vieri, M.
    Savino, A. M.
    Fazio, G.
    Geertruy, T. K.
    Basso, G.
    Cazzaniga, G.
    Biondi, A.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S101 - S101
  • [27] Impact of the MLL breakpoint on the development of MLL-rearranged leukemia
    Bruestl, S.
    Fitzel, R.
    Korkmaz, F.
    Erkner, E.
    Keppeler, H.
    Mankel, B.
    Secker, K. -A
    Lengerke, C.
    Schneidawind, D.
    Schneidawind, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 116 - 116
  • [28] Identification Of BCL6 As a Therapeutic Target In MLL-Rearranged ALL
    Hurtz, Christian
    Geng, Huimin
    Ballabio, Erica
    Xiao, Gang
    Ng, Carina
    Masouleh, Behzad Kharabi
    Willman, Cheryl L.
    Armstrong, Scott A.
    Milne, Thomas
    Melnick, Ari
    Muschen, Markus
    BLOOD, 2013, 122 (21)
  • [29] MicroRNAs mark in the MLL-rearranged leukemia
    Leonidas Benetatos
    George Vartholomatos
    Annals of Hematology, 2013, 92 : 1439 - 1450
  • [30] Paradoxical Effects of MLL Paralogs in MLL-Rearranged Leukemia
    Thirman, Michael J.
    CANCER CELL, 2017, 31 (06) : 729 - 731
12345